跳至主要内容
临床试验/NCT01724983
NCT01724983Unknown3 期

Effects of Ketamine on Recovery From Bariatric Surgery

University of Padova1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2012年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
90
试验地点
1
主要终点
pain level

研究概览

简要总结

Ketamine may improve recovery from bariatric surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 18
  • obesity (Body Mass Index > 30)
  • ASA classificazion < 4
  • candidate to bariatric surgery

排除标准

  • known or presumed pregnancy
  • previous surgery on the airway, esophagus or stomach
  • uncontrolled psychiatric symptomatology

研究组 & 干预措施

ketamine

Experimental

patients will receive ketamine at induction

干预措施: ketamine (Drug)

fentanyl

Active Comparator

patients will receive fentanyl at induction

干预措施: fentanyl (Drug)

结局指标

主要结局

pain level

时间窗: postoperatively, up to 3 months

mood level

时间窗: postoperatively, up to 3 months

次要结局

  • total dosages of analgesic and muscle relaxant drugs(postoperatively, up to 3 months)
  • postanesthetic recovery(postoperatively, up to 24 hours)
  • satisfaction of the patient and of the surgeon(day 1)
  • pulse oximetry saturation(postoperatively, up to 24 hours)
  • lung volumes(postoperatively, up to 48 hours from end of surgery)
  • antihemetic drug dosage(postoperatively, up to 24 hours)
  • vasoactive drugs(intraoperatively and up to 24 hours from surgery end)

研究者

发起方
University of Padova
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Ketamine in Bariatric Surgery | 临床试验